Overview
Brian focuses on protecting his clients’ innovations through strategic patent litigation across biotechnology, pharmaceuticals, medical devices, and other complex technologies. Recognized as a Best Lawyers: Ones to Watch 2025 honoree, he represents innovators and companies in intellectual property disputes, guiding them through infringement actions and defenses with a practical, results-driven approach.
Brian has helped secure significant patent litigation wins for his clients in a variety of forums, including U.S. Federal District Courts, the U.S. Court of Appeals for the Federal Circuit, and the Patent Trial and Appeal Board (PTAB). He has litigated cases involving a wide range of medical device technologies, including cardiovascular devices such as heart valves and valve repair devices, vascular technologies including thrombectomy systems. Brian has also represented generic pharmaceutical companies in numerous litigations under the Hatch-Waxman Act.
Recognized as a top performer before the PTAB, Brian has obtained cancellation of challenged patent claims in numerous inter partes reviews (IPRs). He has also helped his clients navigate the changing PTAB landscape, including the evolving procedures and practices for discretionary denial of IPR institutions.
No matter the forum or technology, Brian uses his scientific and legal training, including as a Federal Circuit law clerk, to secure the best outcomes for his clients.
Brian attended Duke University School of Law, where he served as an editor of the Duke Law Journal.
Clerk Experience
Judicial Law Clerk to the Honorable Todd M. Hughes, United States Court of Appeals for the Federal Circuit, 2018-2019
Education
- Duke University (J.D., 2018), Summa Cum Laude, Order of the Coif, Class of 2018 Intellectual Property and Technology Law Faculty Award
- University of Nevada - Reno (B.S. Biochemistry & Molecular Biology, 2015), Magna Cum Laude
Recognition
Awards & Honors
- Recognized in the “Best Lawyers 2026 Guide: Ones to Watch” for Intellectual Property Law in Best Lawyers in America (2025)
News & Insights
Articles
Litigation Blog
- Deleted Definition “Highly Significant” for Claim Construction
- PTAB Need Not Consider Mountain of Evidence Submitted Without a Map
- Seeing Clearly: An Ordinary Observer Must Look Through Lens of the Prior Art
- Silence Is No Support for Negative Claim Limitation
- No Special Standards for Nexus of Objective Indicia Apply to Design Patents
- Federal Circuit Remands CBM Appeals Under Arthrex, Leaves Forum Selection Dispute for Another Day